In another signal of the appetite among investors for companies applying artificial intelligence to drug discovery, Pathos AI has gathered an impressive $365 million in fourth-round financing as it ...

Making demographic comparisons across datasets and across time requires rigor and consistency in group definitions. Without this, one risks reporting change that is not real. Since some of our ...

Waseem is a writer here at GameRant. He can still feel the pain of Harry Du Bois in Disco Elysium, the confusion of Alan Wake in the Remedy Connected Universe, the force of Ken's shoryukens and the ...

London-listed PRTech firm Pathos Communications has created PathosMind, a proprietary AI platform built exclusively for use by its employees and partners. The platform is designed to identify stories ...

Developed by London Stock Exchange–listed MediaTech firm Pathos Communications, PathosMind is a proprietary AI platform designed to surface stories that truly resonate with audiences. By scanning more ...

(Alliance News) - Pathos Communications PLC on Wednesday said it expects a market capitalisation of GBP20.0 million on admission to London's AIM, as it confirmed the expected admission date is on ...

A British marketing agency ranked among Europe's fastest-growing businesses is planning to float on the London Stock Exchange later this month, The Mail on Sunday understands. Pathos Communications, ...

From infomercials to political canvassing to appeals for coveted roles, the most compelling rhetoric uses a mix of ethos, pathos, and logos. These techniques encompass a wide spectrum of human ...

Increased global competition has fuelled disruption and competition in almost all industries. There are notable exceptions, however, where businesses are not spoilt for choice. One of those is in the ...

Pathos AI Inc., a startup using artificial intelligence to develop new oncology drugs, today announced that it has raised $365 million in a late-stage funding. The company didn’t disclose the ...

Gift Article 10 Remaining As a subscriber, you have 10 articles to gift each month. Gifting allows recipients to access the article for free. Pathos AI, the biotech drug developer spun out of Tempus ...